Pasadena / Valencia / Austin / Mannheim / Rutherford / Manassas / San Diego / Flanders / /
Company
Maxim Pharmaceuticals Inc. / Qiagen / Becton Dickinson / Cambrex / Ford / PerkinElmer / /
Country
Germany / United States / / /
Facility
Veterans Hospital / Centre Hospitalier de l’Universite Laval Research Centre / Scale bar / California Institute of Technology / La Jolla Institute / /
IndustryTerm
active site / natural product / death machinery / cancer therapy / database search / siRNA technology leads / cancer treatment / transferrin binding site / chemical genetics / /
MedicalCondition
hereditary hemochromatosis / rodent tumor / glioma / colon cancers / T47D breast cancer / MS / cancers / tumor / cancer / J. Cancer / resistant human uterine sarcoma / certain cancers / treatment-resistant cancers / /
MedicalTreatment
traditional Chinese medicine / cancer therapy / /
Organization
California Institute of Technology / Veterans Hospital / ND ND / National Academy of Sciences / l’Universite Laval Research Centre / Division of Cellular Immunology / La Jolla Institute for Allergy and Immunology / /
Person
John Drewe / Nicole M. English / Anthony E. Ponce / Jean Yu Wang / Sergei Maliartchouk / Katayoun A. Jessen / ACA TCC TGA / Shannon P. Archer / Ben Tseng / Pamela J. Bjorkman / Ling Qiu / Kurt R. Gehlsen / Sue-Ann Woo / Douglas R. Green / Candace CroganGrundy / /
Position
R. N. / executioner / Representative / /
Product
paclitaxel / /
ProvinceOrState
Quebec / S.K. / California / Georgia / /
Technology
Proteomics / antibodies / siRNA / siRNA technology / apoptosis / pharmacokinetics / drug delivery / drug discovery / treating cancer / /
A role for transferrin receptor in triggering apoptosis when targeted with gambogic acid Shailaja Kasibhatla*†, Katayoun A. Jessen*, Sergei Maliartchouk*, Jean Yu Wang*, Nicole M. English*, John Drewe*,